首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of drug targeting

缩写:J DRUG TARGET

ISSN:1061-186X

e-ISSN:1029-2330

IF/分区:4.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1790
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yukinobu Kodama,Hiroki Hanamura,Takahiro Muro et al. Yukinobu Kodama et al.
Fetuin is a biocompatible plasma protein and strongly enhances phagocytosis of bacteria, DNA and apoptotic cells by peripheral blood cells such as monocytes, macrophages and dendritic cells. We developed a novel gene delivery system: ternar...
Tao Wang,Radhika Narayanaswamy,Huilan Ren et al. Tao Wang et al.
Pancreatic cancer has been a life-threatening illness associated with high incidence and mortality rates. Paclitaxel (PCT) that causes mitotic arrest in cancer cells disrupting microtubule function is used for pancreatic cancer treatment. N...
Junxia Wang,Wuli Zhao,Hong Liu et al. Junxia Wang et al.
Human myofibrillogenesis regulator 1 (MR-1) is a functional gene also known as paroxysmal nonkinesigenic dyskinesia (PNKD). It is localised on human chromosome 2q35 and three different isomers, MR-1L, MR-1M and MR-1S, are formed by alternat...
Ana Luiza Chaves Maia,Carolina de Aguiar Ferreira,André Luis Branco de Barros et al. Ana Luiza Chaves Maia et al.
Despite advances in the development of new therapeutic agents and diagnostic imaging techniques, the 5-year survival of osteosarcoma, the most common type of bone cancer, remains practically unaltered for the last three decades at around 60...
Kıvılcım Öztürk-Atar,Hakan Eroğlu,Sema Çalış Kıvılcım Öztürk-Atar
Developing a new drug molecule is not only time-consuming and expensive, but also mostly a failing process. However, improving bioavailability, targetability, efficacy or safety of old drugs could be more effective way to use them in clinic...
Sebastien Taurin,Aliyah A Almomen,Tatianna Pollak et al. Sebastien Taurin et al.
Vaginal drug delivery represents an attractive strategy for local and systemic delivery of drugs otherwise poorly absorbed after oral administration. The rather dense vascular network, mucus permeability and the physiological phenomenon of ...
Chun Y Wong,Hani Al-Salami,Crispin R Dass Chun Y Wong
Therapeutic peptides are conventionally administered via subcutaneous injection. Chitosan-based nanoparticles are gaining increased attention for their ability to serve as a carrier for oral delivery of peptides and vaccination. They offere...
Ankush Sharma,Amit K Goyal,Goutam Rath Ankush Sharma
Metal nanoparticles (NPs) may have the potential to overcome problems related to conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in cancer therapy providing better targeting, gene silencing and drug deli...
Noha Nafee,Mariam Zewail,Nabila Boraie Noha Nafee
Alendronate (ALN) is a BCS III bone resorption inhibitor, with very poor oral bioavailability. Our approach is to develop a minimally invasive thermogelling system for prolonged local delivery of ALN. For this, different chitosan-based ther...
Uday Krishna Baruah,Kuppusamy Gowthamarajan,Vanka Ravisankar et al. Uday Krishna Baruah et al.
Chloroquine was once the most widely used antimalarial for nearly eight decades for its safety, efficiency, stability, low cost and finally for its less toxic nature. But its use and efficacy got slowly decreased with the increase of chloro...